Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression and Survival in Operable Squamous-Cell Laryngeal Cancer

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Mountzios, Giannis ^a   Kostopoulos, Ioannis ^b   Kotoula, Vassiliki ^b   Sfakianaki, Ioanna ^b   Fountzilas, Elena ^b   Markou, Konstantinos ^b   Karasmanis, Ilias ^c   Leva, Sofia ^b   Angouridakis, Nikolaos ^b   Vlachtsis, Konstantinos ^b   Nikolaou, Angelos ^c   Konstantinidis, Ioannis ^d   Fountzilas, George ^b  

^a IASO GENERAL HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c G PAPANICOLAOU HOSPITAL   (Greece)

^d PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INSULIN LIKE GROWTH FACTOR 1 RECEPTOR ALPHA; INSULIN LIKE GROWTH FACTOR 1 RECEPTOR BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 9; ONCOPROTEIN; PROTEIN MAP2K1; PROTEIN PIK3CA; PROTEIN PIK3R1; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C RECEPTOR; SUPPRESSOR OF CYTOKINE SIGNALING 2; UNCLASSIFIED DRUG; IGFBP3 PROTEIN, HUMAN; ISOPROTEIN; MAP2K1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; SOCS2 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; CLINICAL FEATURE; DISEASE FREE SURVIVAL; DISEASE MARKER; DNA SEQUENCE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX SQUAMOUS CELL CARCINOMA; LARYNX SURGERY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PREDICTIVE VALUE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; GENE EXPRESSION; GENETICS; LARYNX TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; SQUAMOUS CELL CARCINOMA; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; LARYNGEAL NEOPLASMS; MALE; MAP KINASE KINASE 1; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 9; NEOPLASM STAGING; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN ISOFORMS; RECEPTOR, IGF TYPE 1; RECEPTOR, IGF TYPE 2; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84872834749     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054048     Document Type: Article

References (33)

1. Thomas L, Drinnan M, Natesh B, Mehanna H, Jones T, et al. (2012) Open conservation partial laryngectomy for laryngeal cancer: a systematic review of English language literature. Cancer Treat Rev 38 (3) (): 203-11.
2. Lefebvre JL, (2012) Larynx preservation. Curr Opin Oncol 24 (3) (): 218-22.
3. Cappuzzo F, Tallini G, Finocchiaro G, Wilson RS, Ligorio C, et al. (2010) Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients. Ann Oncol 21 (3) (): 562-7.
4. Dziadziuszko R, Merrick DT, Witta SE, Mendoza AD, Szostakiewicz B, et al. (2010) Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression. J Clin Oncol 28 (13) (): 2174-80.
5. Ciampolillo A, De Tullio C, Perlino E, Maiorano E, (2007) The IGF-I axis in thyroid carcinoma. Curr Pharm Des 13 (7) (): 729-35.
6. Malaguarnera R, Frasca F, Garozzo A, (2011) Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. J Clin Endocrinol Metab 96 (3) (): 766-74.
7. Doyle SL, Donohoe CL, Finn SP, Howard JM, Lithander FE, et al. (2012) IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity. Am J Gastroenterol 107 (2) (): 196-204.
8. Meyer F, Samson E, Douville P, Duchesne T, Liu G, et al. (2010) Serum prognostic markers in head and neck cancer. Clin Cancer Res 16 (3) (): 1008-15.
9. Kim JS, Kim ES, Liu D, Lee JJ, Solis L, et al. (2012) Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer. Cancer 118 (9) (): 2454-6.
10. Pollak M, (2012) The insulin receptor/insulin-like growth factor receptor family as a therapeutic target in oncology. Clin Cancer Res 18 (1) (): 40-50.
11. Sabapathy K, Wagner EF, (2004) JNK2: a negative regulator of cellular proliferation. Cell Cycle 3 (12) (): 1520-3.
12. Krebs DL, Hilton DJ, (2003) A new role for SOCS in insulin action. Suppressor of cytokine signaling. Sci STKE (169) pp. PE6.
13. Leroith D, Nissley P, (2005) Knock your SOCS off!. J Clin Invest 115 (2) (): 233-6.
14. Blumenschein G Jr, (2011) Insulin-like growth factor receptor. J Thorac Oncol 6 (11 Suppl 4) (): S1799-800.
15. Niu J, Huang YJ, Wei, Liu Z, Wang LE, et al. (2011) Association between a functional polymorphism (-1195T>C) in the IGFBP5 promoter and head and neck cancer risk. Head Neck 33 (5) (): 650-60.
16. Oh SH, Kim WY, Lee OH, Kang JH, Woo JK, et al. (2012) Insulin-like growth factor binding protein-3 suppresses vascular endothelial growth factor expression and tumor angiogenesis in head and neck squamous cell carcinoma. Cancer Sci doi:10.1111/j.1349-7006.2012.02301.x.
17. Jameson MJ, Beckler AD, Taniguchi LE, Allak A, Vanwagner LB, et al. (2011) Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells. Mol Cancer Ther 10 (11) (): 2124-34.
18. Chung CH, Pohlmann PR, Rothenberg ML, Burkey BB, Parker J, et al. (2011) Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma. Head Neck (33) (12) pp. 1804-8.
19. Liu S, Jin F, Dai W, Yu Y, (2010) Antisense treatment of IGF-IR enhances chemosensitivity in squamous cell carcinomas of the head and neck. Eur J Cancer 46 (9) (): 1744-51.
20. Friedrich RE, Hagel C, Bartel-Friedrich S, (2010) Insulin-like growth factor-1 receptor (IGF-1R) in primary and metastatic undifferentiated carcinoma of the head and neck: a possible target of immunotherapy. Anticancer Res 30 (5) (): 1641-3.
21. Victory K, Burd R, Fribley A, Sittadjody S, Arnett D, et al. (2011) Head and neck tumor cell radiation response occurs in the presence of IGF1. J Dent Res 90 (3) (): 347-52.
22. Fountzilas E, Markou K, Vlachtsis K, Nikolaou A, Arapantoni-Dadioti P, et al. (2012) Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancer. Ann Oncol 23 (8) (): 2146-53.
23. Sanchez-Navarro I, Gamez-Pozo A, Gonzalez-Baron M, Pinto-Marín A, Hardisson D, et al. (2010) Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues. Biotechniques 48 (5) (): 389-97.
24. Hennig G, Gehrmann M, Stropp U, Brauch H, Fritz P, et al. (2010) Automated extraction of DNA and RNA from a single formalin-fixed paraffin-embedded tissue section for analysis of both single-nucleotide polymorphisms and mRNA expression. Clin Chem 56 (12) (): 1845-53.
25. Penteroudakis G, Nicolaou I, Kotoula V, Fountzilas E, Markou K, et al. (2012) Prognostic utility of angiogenesis and hypoxia effectors in patients with operable squamous cell cancer of the larynx. Oral Oncol doi:10,1016/j.oraloncology.2012.02.002 [E-Pub ahead of print].
26. Chui X, Egami H, Yamashita J, Kurizaki T, Ohmachi H, et al. (1996) Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues. Br. J Cancer 73: 1233-1236.
27. Friedrichs K, Gluba S, Eidtmann H, Jonat W, (1993) Overexpression of p53 and prognosis in breast cancer. Cancer 72: 3641-3647.
28. McShane LM, Altman DG, Sauerbrei W, Taube SE, (2005) Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 23: 9067-9072.
29. Cappuzzo F, Toschi L, Tallini G, Ceresoli GL, Domenichini I, et al. (2006) Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib. Ann Oncol 17 (7) (): 1120-7.
30. Papadimitrakopoulou VA, Brown EN, Liu DD, El-Naggar AK, Jack Lee J, et al. (2006) The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis. Cancer Lett 239 (1) (): 136-43.
31. Li S, Cha J, Kim J, Kim KY, Kim HJ, et al. (2011) Insulin-like growth factor II mRNA-binding protein 3: a novel prognostic biomarker for oral squamous cell carcinoma. Head Neck 33 (3) (): 368-74.
32. Sun JM, Jun HJ, Ko YH, Park YH, Ahn YC, et al. (2011) Insulin-like growth factor binding protein-3, in association with IGF-1 receptor, can predict prognosis in squamous cell carcinoma of the head and neck. Oral Oncol 47 (8) (): 714-9.
33. Grbesa I, Ivkic M, Pegan B, Gall-Troselj K, (2006) Loss of imprinting and promoter usage of the IGF2 in laryngeal squamous cell carcinoma. Cancer Lett 238 (2) (): 224-9.